|
Trinity Biotech PLC - Comparative Business Analysis Snapshot
Business Description
Trinity Biotech PLC. The Group's principal activity is developing, manufacturing and marketing diagnostic test kits used for the clinical laboratory and point-of-care segments of the diagnostic market. These test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders and autoimmune disorders. The Group is also a provider of raw materials to the life sciences industry. Products brands are Amax, Biopool, CAPTIA, Macra, MicroTrak, Uni-Gold, Amelung, Bartels, Capillus, SeroCard, Recombigen and MarDx. The Group operates in Ireland, the United Kingdom, the United States of America, Germany and Sweden.
Competitor Analysis
This analysis compares Trinity Biotech PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
